JPMorgan Chase & Co’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.07B | Sell |
3,939,618
-1,718,579
| -30% | -$902M | 0.14% | 141 |
|
|
2025
Q1 | $3.59B | Sell |
5,658,197
-1,401,174
| -20% | -$889M | 0.26% | 81 |
|
|
2024
Q4 | $5.03B | Sell |
7,059,371
-430,129
| -6% | -$306M | 0.37% | 44 |
|
|
2024
Q3 | $7.87B | Sell |
7,489,500
-787,815
| -10% | -$828M | 0.6% | 21 |
|
|
2024
Q2 | $8.7B | Buy |
8,277,315
+550,141
| +7% | +$578M | 0.71% | 18 |
|
|
2024
Q1 | $7.44B | Buy |
7,727,174
+500,405
| +7% | +$482M | 0.63% | 20 |
|
|
2023
Q4 | $6.35B | Sell |
7,226,769
-162,385
| -2% | -$143M | 0.61% | 18 |
|
|
2023
Q3 | $6.08B | Buy |
7,389,154
+845,167
| +13% | +$696M | 0.67% | 21 |
|
|
2023
Q2 | $4.7B | Buy |
6,543,987
+199,836
| +3% | +$144M | 0.51% | 28 |
|
|
2023
Q1 | $5.21B | Buy |
6,344,151
+234,606
| +4% | +$193M | 0.64% | 22 |
|
|
2022
Q4 | $4.41B | Buy |
6,109,545
+403,676
| +7% | +$291M | 0.58% | 23 |
|
|
2022
Q3 | $3.93B | Buy |
5,705,869
+27,437
| +0.5% | +$18.9M | 0.56% | 24 |
|
|
2022
Q2 | $3.36B | Buy |
5,678,432
+713,465
| +14% | +$422M | 0.47% | 35 |
|
|
2022
Q1 | $3.47B | Buy |
4,964,967
+373,438
| +8% | +$261M | 0.42% | 43 |
|
|
2021
Q4 | $2.9B | Buy |
4,591,529
+489,084
| +12% | +$309M | 0.33% | 58 |
|
|
2021
Q3 | $2.48B | Buy |
4,102,445
+314,052
| +8% | +$190M | 0.31% | 63 |
|
|
2021
Q2 | $2.12B | Buy |
3,788,393
+752,738
| +25% | +$420M | 0.25% | 79 |
|
|
2021
Q1 | $1.44B | Buy |
3,035,655
+721,261
| +31% | +$341M | 0.19% | 116 |
|
|
2020
Q4 | $1.12B | Buy |
2,314,394
+391,040
| +20% | +$189M | 0.16% | 132 |
|
|
2020
Q3 | $1.1B | Buy |
1,923,354
+125,884
| +7% | +$72.2M | 0.19% | 112 |
|
|
2020
Q2 | $1.12B | Buy |
1,797,470
+568,057
| +46% | +$354M | 0.22% | 103 |
|
|
2020
Q1 | $600M | Buy |
1,229,413
+9,526
| +0.8% | +$4.65M | 0.14% | 151 |
|
|
2019
Q4 | $458M | Buy |
1,219,887
+764,436
| +168% | +$287M | 0.09% | 237 |
|
|
2019
Q3 | $126M | Sell |
455,451
-96,471
| -17% | -$26.8M | 0.03% | 547 |
|
|
2019
Q2 | $171M | Sell |
551,922
-743,350
| -57% | -$231M | 0.03% | 470 |
|
|
2019
Q1 | $532M | Buy |
1,295,272
+1,036,855
| +401% | +$426M | 0.11% | 195 |
|
|
2018
Q4 | $96.5M | Buy |
258,417
+28,807
| +13% | +$10.8M | 0.02% | 577 |
|
|
2018
Q3 | $92.8M | Buy |
229,610
+78,013
| +51% | +$31.5M | 0.02% | 674 |
|
|
2018
Q2 | $52.3M | Sell |
151,597
-11,631
| -7% | -$4.01M | 0.01% | 859 |
|
|
2018
Q1 | $56.2M | Sell |
163,228
-52,160
| -24% | -$18M | 0.01% | 806 |
|
|
2017
Q4 | $81M | Sell |
215,388
-129,030
| -37% | -$48.5M | 0.02% | 690 |
|
|
2017
Q3 | $150M | Buy |
344,418
+119,508
| +53% | +$52M | 0.03% | 466 |
|
|
2017
Q2 | $110M | Sell |
224,910
-53,739
| -19% | -$26.4M | 0.03% | 548 |
|
|
2017
Q1 | $108M | Sell |
278,649
-58,522
| -17% | -$22.7M | 0.02% | 550 |
|
|
2016
Q4 | $124M | Sell |
337,171
-697,019
| -67% | -$257M | 0.03% | 475 |
|
|
2016
Q3 | $417M | Sell |
1,034,190
-401,961
| -28% | -$162M | 0.1% | 208 |
|
|
2016
Q2 | $502M | Sell |
1,436,151
-27,541
| -2% | -$9.62M | 0.13% | 176 |
|
|
2016
Q1 | $528M | Sell |
1,463,692
-1,189,931
| -45% | -$429M | 0.14% | 163 |
|
|
2015
Q4 | $1.44B | Buy |
2,653,623
+114,453
| +5% | +$62.1M | 0.36% | 50 |
|
|
2015
Q3 | $1.18B | Buy |
2,539,170
+103,791
| +4% | +$48.3M | 0.32% | 57 |
|
|
2015
Q2 | $1.24B | Buy |
2,435,379
+160,171
| +7% | +$81.7M | 0.29% | 61 |
|
|
2015
Q1 | $1.03B | Buy |
2,275,208
+512,962
| +29% | +$232M | 0.23% | 84 |
|
|
2014
Q4 | $723M | Buy |
1,762,246
+218,398
| +14% | +$89.6M | 0.17% | 126 |
|
|
2014
Q3 | $557M | Sell |
1,543,848
-136,585
| -8% | -$49.2M | 0.13% | 164 |
|
|
2014
Q2 | $475M | Buy |
1,680,433
+104,139
| +7% | +$29.4M | 0.12% | 186 |
|
|
2014
Q1 | $473M | Sell |
1,576,294
-274,063
| -15% | -$82.3M | 0.13% | 175 |
|
|
2013
Q4 | $509M | Sell |
1,850,357
-707,221
| -28% | -$195M | 0.14% | 157 |
|
|
2013
Q3 | $800M | Sell |
2,557,578
-331,959
| -11% | -$104M | 0.24% | 85 |
|
|
2013
Q2 | $650M | Buy |
+2,889,537
| New | +$650M | 0.21% | 98 |
|